MENUNews Archive
Date: 10/19/2020
Today, F. DuBois Bowman, Justin B. Dimick, Christopher R. Friese, Karin M. Muraszko and Henry L. Paulson join a select group of fewer than 60 current and emeritus U-M faculty, and living former faculty, in the National Academy of Medicine. Drs. Friese and Muraszko are cancer center members.
Date: 10/12/2020
Survival rates for women with inflammatory breast cancer have nearly doubled, but analysis shows an ongoing disparity between the survival rates of white patients and Black patients.
Date: 10/07/2020
The Ovarian Cancer Initiative at Michigan Medicine has received a generous bequest from Beth J. Johnson. It is the culmination of her dedicated efforts and extensive volunteer work for the initiative
Date: 10/01/2020
With a new $7.2 million grant from the National Cancer Institute, Rogel Cancer Center researchers and their national collaborators will test whether blocking inflammatory processes could protect cells and potentially prevent some cancers.
Date: 09/28/2020
Researchers at the Rogel Cancer Center have developed a new diagnostic approach using artificial intelligence that aims to do exactly that — and with greater than 90% accuracy
Date: 09/28/2020
By distilling information from hundreds of data sources, including published genome-wide association studies (GWAS) and meta-analyses, Rogel Cancer Center researchers generated polygenic risk scores (PRS) for 35 common types of cancer.
Date: 09/25/2020
A new expressive writing tool called Making Meaning allows people to put their thoughts and feelings into words to help relieve stress and anxiety.
Date: 09/24/2020
Researchers at the Medicine C.S Mott Children’s Hospital and the U-M Rogel Cancer Center have been breaking new ground in understanding and treating childhood brain cancers, including some of the most serious and aggressive types of tumors.
Date: 09/23/2020
Postdoctoral training is to bench scientists what residency programs are to medical students — a period of mentored apprenticeship to bridge the gap between one’s student years and an independent career.
Date: 09/20/2020
A new inhibitor designed to target what’s been called an “undruggable” genetic mutation showed promising activity against advanced cancers with this mutation.